Work

The effect of pembrolizumab in combination with CD19-targeted chimeric antigen receptor (CAR) T cells in relapsed acute lymphoblastic leukemia (ALL).

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.103

Authors: Shannon L. Maude, George E Hucks, Alix Eden Seif, Mala Kiran Talekar, David T. Teachey, Diane Baniewicz, Colleen Callahan, Vanessa Gonzalez, Farzana Nazimuddin, Minnal Gupta, Noelle V. Frey, David L. Porter, Bruce L Levine, Jan J. Melenhorst, Simon F. Lacey, Carl H. June, Stephan A. Grupp

Institutions: Children's Hospital of Philadelphia, University of Pennsylvania

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2621883146

Cites:

Cited by: 98

Related to: 10